Peterson RE
Patients with high GLP-1 receptor sensitivity often clear brain fog faster, while those with specific metabolic variants may benefit from extended treatment timelines
Id love to see a dosing trial of patients like this, perhaps looking at smaller initiation doses, or spreading the doses out differently, either by less frequent dosing, or more frequent but lower doses that still get to the same eventual pharmacologic levels
Her intelligence quotient was measured as 30, and type 2 DM and hypertension were diagnosed when she was 16 years old and were treated with metformin and a calcium channel blocker, respectively
ANDREW HUBERMAN: Do you take coenzyme Q10
Shantel will tell you what's likely going on, what's realistic, and what to do next